Labyrin en es it fr

Labyrin Brand names, Labyrin Analogs

Labyrin Brand Names Mixture

  • No information avaliable

Labyrin Chemical_Formula

C26H28N2

Labyrin RX_link

No information avaliable

Labyrin fda sheet

Labyrin msds (material safety sheet)

Labyrin Synthesis Reference

No information avaliable

Labyrin Molecular Weight

368.514 g/mol

Labyrin Melting Point

No information avaliable

Labyrin H2O Solubility

750 mg/L

Labyrin State

Solid

Labyrin LogP

5.63

Labyrin Dosage Forms

No information avaliable

Labyrin Indication

For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.

Labyrin Pharmacology

Cinnarizine is an antihistamine and a calcium channel blocker. Histamines mediate a number of activities such as contraction of smooth muscle of the airways and gastrointestinal tract, vasodilatation, cardiac stimulation, secretion of gastric acid, promotion of interleukin release and chemotaxis of eosinophils and mast cells. Competitive antagonists at histamine H1 receptors may be divided into first (sedating) and second (non-sedating) generation agents. Some, such as Cinnarizine also block muscarinic acetylcholine receptors and are used as anti-emetic agents. Cinnarizine through its calcium channel blocking ability also inhibits stimulation of the vestibular system.

Labyrin Absorption

No information avaliable

Labyrin side effects and Toxicity

No information avaliable

Labyrin Patient Information

No information avaliable

Labyrin Organisms Affected

Humans and other mammals